These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 23802074)

  • 1. Human Vδ2 versus non-Vδ2 γδ T cells in antitumor immunity.
    Kabelitz D; Kalyan S; Oberg HH; Wesch D
    Oncoimmunology; 2013 Mar; 2(3):e23304. PubMed ID: 23802074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toll-like receptor expression and function in subsets of human gammadelta T lymphocytes.
    Pietschmann K; Beetz S; Welte S; Martens I; Gruen J; Oberg HH; Wesch D; Kabelitz D
    Scand J Immunol; 2009 Sep; 70(3):245-55. PubMed ID: 19703014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. COVID-19 vaccination influences subtypes of γδ-T cells during pregnancy.
    Wang L; Li J; Jiang S; Li Y; Guo R; Chen Y; Chen Y; Yu H; Qiao Q; Zhan M; Yin Z; Xiang Z; Xu C; Xu Y
    Front Immunol; 2022; 13():900556. PubMed ID: 36311780
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heterogeneity of Human γδ T Cells and Their Role in Cancer Immunity.
    Lee HW; Chung YS; Kim TJ
    Immune Netw; 2020 Feb; 20(1):e5. PubMed ID: 32158593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vδ1 Effector and Vδ2 γδ T-Cell Subsets Shift in Frequency and Are Linked to Plasma Inflammatory Markers During Antiretroviral Therapy-Suppressed HIV Infection.
    Pihl RMF; Smith-Mahoney EL; Olson A; Yuen RR; Asundi A; Lin N; Belkina AC; Snyder-Cappione JE
    J Infect Dis; 2024 May; 229(5):1317-1327. PubMed ID: 38390982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vδ2 T cells are associated with favorable clinical outcomes in patients with bladder cancer and their tumor reactivity can be boosted by BCG and zoledronate treatments.
    Nguyen S; Chevalier MF; Benmerzoug S; Cesson V; Schneider AK; Rodrigues-Dias SC; Dartiguenave F; Lucca I; Jichlinski P; Roth B; Nardelli-Haefliger D; Derré L
    J Immunother Cancer; 2022 Aug; 10(8):. PubMed ID: 36002184
    [No Abstract]   [Full Text] [Related]  

  • 7. Exhausted intratumoral Vδ2
    Rancan C; Arias-Badia M; Dogra P; Chen B; Aran D; Yang H; Luong D; Ilano A; Li J; Chang H; Kwek SS; Zhang L; Lanier LL; Meng MV; Farber DL; Fong L
    Nat Immunol; 2023 Apr; 24(4):612-624. PubMed ID: 36928415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term use of interferon-β in multiple sclerosis increases Vδ1
    Maimaitijiang G; Watanabe M; Shinoda K; Isobe N; Nakamura Y; Masaki K; Matsushita T; Yoshikai Y; Kira JI
    J Neuroinflammation; 2019 Sep; 16(1):179. PubMed ID: 31519178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune response of human propagated gammadelta-T-cells to neuroblastoma recommend the Vdelta1+ subset for gammadelta-T-cell-based immunotherapy.
    Schilbach K; Frommer K; Meier S; Handgretinger R; Eyrich M
    J Immunother; 2008; 31(9):896-905. PubMed ID: 18832998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blocking of EphA2 on Endometrial Tumor Cells Reduces Susceptibility to Vδ1 Gamma-Delta T-Cell-Mediated Killing.
    Hudecek R; Kohlova B; Siskova I; Piskacek M; Knight A
    Front Immunol; 2021; 12():752646. PubMed ID: 34691070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Characteristics of γδ T cell subsets induced from peripheral blood mononuclear cells of HIV/AIDS patients in vitro].
    Chen WW; Wu XL; Nie WM; Xie YX; Wang L; Zhao M
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2012 Mar; 28(3):285-7. PubMed ID: 22394638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of tumor-infiltrating gamma delta T cells in rectal cancer.
    Rong L; Li K; Li R; Liu HM; Sun R; Liu XY
    World J Gastroenterol; 2016 Apr; 22(13):3573-80. PubMed ID: 27053849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human Vδ1 γδ T cells expanded from peripheral blood exhibit specific cytotoxicity against B-cell chronic lymphocytic leukemia-derived cells.
    Siegers GM; Dhamko H; Wang XH; Mathieson AM; Kosaka Y; Felizardo TC; Medin JA; Tohda S; Schueler J; Fisch P; Keating A
    Cytotherapy; 2011 Jul; 13(6):753-64. PubMed ID: 21314241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proportions of blood-borne Vδ1+ and Vδ2+ T-cells are associated with overall survival of melanoma patients treated with ipilimumab.
    Wistuba-Hamprecht K; Martens A; Haehnel K; Geukes Foppen M; Yuan J; Postow MA; Wong P; Romano E; Khammari A; Dreno B; Capone M; Ascierto PA; Demuth I; Steinhagen-Thiessen E; Larbi A; Schilling B; Schadendorf D; Wolchok JD; Blank CU; Pawelec G; Garbe C; Weide B
    Eur J Cancer; 2016 Sep; 64():116-26. PubMed ID: 27400322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenotypic and functional heterogeneity of peripheral γδ T cells in pulmonary TB and HIV patients in Addis Ababa, Ethiopia.
    Negash M; Tsegaye A; Wassie L; Howe R
    BMC Infect Dis; 2018 Sep; 18(1):464. PubMed ID: 30219039
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Homeostatic γδ T Cell Contents Are Preserved by Granulocyte Colony-Stimulating Factor Priming and Correlate with the Early Recovery of γδ T Cell Subsets after Haploidentical Hematopoietic Stem Cell Transplantation.
    Bian Z; Xu LP; Fu Q; Huo M; Liu L; Zhao X; Huang XJ; Liu J
    Biol Blood Marrow Transplant; 2018 Feb; 24(2):252-259. PubMed ID: 29061533
    [TBL] [Abstract][Full Text] [Related]  

  • 17. γδ T cell frequencies are altered in HIV positive pregnant South African women and are associated with preterm birth.
    Akoto C; Chan CYS; Ravi K; Zhang W; Vatish M; Norris SA; Hemelaar J
    PLoS One; 2020; 15(6):e0235162. PubMed ID: 32584913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vdelta1 T cells are more resistant than Vdelta2 T cells to the immunosuppressive properties of galectin-3.
    Schadeck J; Oberg HH; Peipp M; Hedemann N; Schamel WW; Bauerschlag D; Wesch D
    Front Immunol; 2023; 14():1286097. PubMed ID: 38259448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Shared reactivity of V{delta}2(neg) {gamma}{delta} T cells against cytomegalovirus-infected cells and tumor intestinal epithelial cells.
    Halary F; Pitard V; Dlubek D; Krzysiek R; de la Salle H; Merville P; Dromer C; Emilie D; Moreau JF; Déchanet-Merville J
    J Exp Med; 2005 May; 201(10):1567-78. PubMed ID: 15897274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antitumor activity of gammadelta T cells reactive against cytomegalovirus-infected cells in a mouse xenograft tumor model.
    Devaud C; Bilhere E; Loizon S; Pitard V; Behr C; Moreau JF; Dechanet-Merville J; Capone M
    Cancer Res; 2009 May; 69(9):3971-8. PubMed ID: 19383918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.